Linda Pax Lowes

12PUBLICATIONS
61CO-AUTHORS
Gene and molecular therapyMedical mycologyMedical infection agents (incl. prions)Neurology and neuromuscular diseasesInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 04, 2026
Five-Year Outcomes With Delandistrogene Moxeparvovec in Patients With Duchenne Muscular Dystrophy: A Phase 1/2a Study.

|Apr 06, 2026
Quantitative Measurement of Glycosylated ⍺-Dystroglycan as a Biomarker for Disease Severity in Limb-Girdle Muscular Dystrophy Type 2I/R9.

John Vissing, Tahseen Mozaffar, Nicholas E Johnson

|Nov 03, 2025
Motor Function in Limb-Girdle Muscular Dystrophy R1/2A: Validation of Clinical Outcome Assessments for Clinical Care and Trial Readiness.

Meredith K James, Megan A Iammarino, Natalie F Reash

|May 13, 2025
A prospective observational study assessing the functional disease progression of LGMDR4, betasarcoglycan-related limb girdle muscular dystrophy.

Megan A Iammarino, Natalie F Reash, Kiana Shannon

|Dec 19, 2024
Psychometric evaluation of the PROMIS parent proxy mobility item bank for use in Duchenne muscular dystrophy.

Linda Pax Lowes, Corinne M Le Reun, Lindsay N Alfano

|May 16, 2024
Validity of remote live stream video evaluation of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy.

Linda P Lowes, Lindsay N Alfano, Megan A Iammarino

Pageof 2

Frequent Collaborators

8 joint publications

Megan Iammarino

7 joint publications

Lindsay N Alfano

3 joint publications

Natalie F Reash

3 joint publications

Marielle G Contesse